De novo generated combinatorial library design
Literature Information
Morteza Haghir Chehreghani
Artificial intelligence (AI) contributes new methods for designing compounds in drug discovery, ranging from de novo design models suggesting new molecular structures or optimizing existing leads to predictive models evaluating their toxicological properties. However, a limiting factor for the effectiveness of AI methods in drug discovery is the lack of access to high-quality data sets leading to a focus on approaches optimizing data generation. Combinatorial library design is a popular approach for bioactivity testing as a large number of molecules can be synthesized from a limited number of building blocks. We propose a framework for designing combinatorial libraries using a molecular generative model to generate building blocks de novo, followed by using k-determinantal point processes and Gibbs sampling to optimize a selection from the generated blocks. We explore optimization of biological activity, Quantitative Estimate of Drug-likeness (QED) and diversity and the trade-offs between them, both in single-objective and in multi-objective library design settings. Using retrosynthesis models to estimate building block availability, the proposed framework is able to explore the prospective benefit from expanding a stock of available building blocks by synthesis or by purchasing the preferred building blocks before designing a library. In simulation experiments with building block collections from all available commercial vendors near-optimal libraries could be found without synthesis of additional building blocks; in other simulation experiments we showed that even one synthesis step to increase the number of available building blocks could improve library designs when starting with an in-house building block collection of reasonable size.
Recommended Journals
Related Literature
Synthesis and spectroscopic observation of dendrimer-encapsulated gold nanoclusters
M. Linh Tran, Andrei V. Zvyagin, Taras Plakhotnik
DOI: 10.1039/B602079H
Bergman cyclopolymerization within the channels of functional hybrid nanocomposites formed by co-assembly of silica and polymerizable surfactant monomer
Chetan Jagdish Bhongale, Chung-He Yang, Chain-Shu Hsu
DOI: 10.1039/B603195A
A new alternative to Stryker's reagent in hydrosilylation: synthesis, structure, and reactivity of a well-defined carbene–copper(ii) acetate complex
Jaesook Yun, Daesung Kim, Hoseop Yun
DOI: 10.1039/B509964A
PAMAM dendrimers for efficient siRNA delivery and potent gene silencing
Jiehua Zhou, Nadia Hafdi, Jean-Paul Behr, Patrick Erbacher
DOI: 10.1039/B601381C
Synthesis of pyrroles: reaction of chromium N-alkylaminocarbene complexes with α,β-unsaturated aldehydes
Kohei Fuchibe, Daisuke Ono, Takahiko Akiyama
DOI: 10.1039/B602924H
Fluorescence based strategies for genetic analysis
Rohan T. Ranasinghe, Tom Brown
DOI: 10.1039/B509522K
Demonstration of the optical limiting effect for an hemiporphyrazine
Danilo Dini, Mario J. F. Calvete, Michael Hanack, Vincenzo Amendola, Moreno Meneghetti
DOI: 10.1039/B601591C
Synthesis of organic–inorganic hybrid mesoporous tin oxophosphate in the presence of anionic surfactant
Masahiro Fujiwara, Masahiko Matsukata
DOI: 10.1039/B508589F
On the influence of porphyrin π–π stacking on supramolecular chirality created in the porphyrin-based twisted tape structure
Masayuki Takeuchi, Satoshi Tanaka, Seiji Shinkai
DOI: 10.1039/B512128K
Non-catalytic and template-free growth of aligned CdS nanowires exhibiting high field emission current densities
Yi-Feng Lin, Yung-Jung Hsu, Shih-Yuan Lu, Sheng-Chin Kung
DOI: 10.1039/B604309G
You might also like
What are the main uses of 1H-Indazole-6-carbonitrile (CAS: 141290-59-7)?
1H-Indazole-6-carbonitrile finds applications in pharmaceuticals, where it serve...
How should waste containing Dioctyl (2E)-2-butenedioate (CAS: 2997-85-5) be handled?
Waste containing Dioctyl (2E)-2-butenedioate (CAS: 2997-85-5) should be collecte...
What industries use Sodium [(1,2-benzoxazol-3-ylmethyl)sulfonyl]azanide (CAS: 68291-98-5)?
Sodium [(1,2-benzoxazol-3-ylmethyl)sulfonyl]azanide is primarily used in pharmac...
Are there alternatives to Dimethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,6-pyridinedicarboxylate (CAS: 741709-66-0) in synthesis?
Dimethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,6-pyridinedicarboxyla...
How should waste containing 2-Fluoro-6-hydrazinopyridine (CAS: 80714-39-2) be handled?
Waste containing 2-Fluoro-6-hydrazinopyridine (CAS: 80714-39-2) should be manage...
What is 6-Formyl-2-pyridinecarboxylic acid (CAS: 499214-11-8)?
6-Formyl-2-pyridinecarboxylic acid is an organic compound with the molecular for...
What is the market or research trend for 3-(3,4-dimethoxyphenyl)-2,5-dimethyl-N-(2-morpholin-4-ylethyl)pyrazolo[1,5-a]pyrimidin-7-amine (CAS: 900874-91-1)?
Research trends for this compound indicate a focus on its potential applications...
How is 9H-Tribenzo[b,d,f]azepine (CAS: 29875-73-8) typically synthesized?
9H-Tribenzo[b,d,f]azepine is typically synthesized via a multi-step process invo...
How is 1-Cyclopropyl-7-ethoxy-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid (CAS: 1797982-51-4) typically synthesized?
1-Cyclopropyl-7-ethoxy-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinolinecarboxyli...
How should waste containing Methyl 3-oxo-1,2,3,4-tetrahydro-6-quinoxalinecarboxylate (CAS: 671820-52-3) be handled?
Waste containing Methyl 3-oxo-1,2,3,4-tetrahydro-6-quinoxalinecarboxylate (CAS: ...













![(1S)-1,5-Anhydro-1-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-D-glucitol structure (1S)-1,5-Anhydro-1-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-D-glucitol structure](https://static.chemtradehub.com/structs/761/761423-87-4-dbeb.webp)

![Sodium 3-[(E)-(4-anilinophenyl)diazenyl]benzenesulfonate structure Sodium 3-[(E)-(4-anilinophenyl)diazenyl]benzenesulfonate structure](https://static.chemtradehub.com/structs/587/587-98-4-035f.webp)